#johnson--johnson

#johnson--johnson

The ETF holds 50 positions, but the top two dominate in a way that makes the rest almost incidental. Johnson & Johnson carries a 25.4% weight, and Eli Lilly and Company sits at 21.4%. Together they account for roughly 46.8% of the entire fund.

The jury in Los Angeles superior court awarded $18m to Monica Kent and $22m to Deborah Schultz and her husband after finding that Johnson & Johnson knew for years its talc-based products were dangerous but failed to warn consumers. Erik Haas, Johnson & Johnson's worldwide vice-president of litigation, said in a statement the company plans to immediately appeal this verdict and expect to prevail as we typically do with aberrant adverse verdicts.

There is no question that this market is obsessed with fast growth and flashy returns, something you can learn just by going online and looking at websites like Reddit and other trading forums. The thing is, dividend compounders win by doing the opposite of flashy, as it rewards patience. Instead of chasing the hype, the best dividend earners forget it and quietly reinvest profits through DRIP.